Search

Your search keyword '"Grant D Stewart"' showing total 353 results

Search Constraints

Start Over You searched for: Author "Grant D Stewart" Remove constraint Author: "Grant D Stewart"
353 results on '"Grant D Stewart"'

Search Results

1. Multiarm, non-randomised, single-centre feasibility study—investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocol

2. Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)

3. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer

4. Reproducibility of CT-based radiomic features against image resampling and perturbations for tumour and healthy kidney in renal cancer patients

5. Reasons for intending to accept or decline kidney cancer screening: thematic analysis of free text from an online survey

6. Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.

7. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

8. How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis

9. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer

10. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT

11. Computerized image analysis of tumor cell nuclear morphology can improve patient selection for clinical trials in localized clear cell renal cell carcinoma

12. Tissue quality assessment using a novel direct elasticity assessment device (the E-finger): a cadaveric study of prostatectomy dissection.

13. Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome.

14. Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer.

15. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma.

16. Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups

17. Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review

20. A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

21. Data from Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer

22. Supplementary Figures 1-2, Supplementary Tables 1-2 from Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer

23. Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment

25. Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer Consortium

27. Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

28. Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy

29. Diagnostic Performance of Biomarkers for Bladder Cancer Detection Suitable for Community and Primary Care Settings: A Systematic Review and Meta-Analysis

30. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

31. Localized renal cancer with inferior vena cava tumour thrombus

32. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

33. Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression

34. HIRA loss transforms FH -deficient cells

35. Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study

36. Should patients with low‐risk renal cell carcinoma be followed differently after nephron‐sparing surgery vs radical nephrectomy?

37. Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma

38. Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study

39. External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer

40. Reproducibility of CT-based radiomic features against image resampling and perturbations for tumour and healthy kidney in renal cancer patients

42. Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma

43. Participants aux Davidson's Principles and Practice of Medicine, 23eédition

45. Identifying opportunities for timely diagnosis of bladder and renal cancer via abnormal blood tests: a longitudinal linked data study

46. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

47. The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer ��� a study protocol

48. Multi-regional characterisation of renal cell carcinoma and microenvironment at single cell resolution

49. Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)

50. Elective cancer surgery in COVID-19–Free surgical pathways during the SARS-cov-2 pandemic: An international, multicenter, comparative cohort study

Catalog

Books, media, physical & digital resources